Literature DB >> 17721642

Quantifying the impact of obesity category on major chronic diseases in Canada.

Ying Jiang1, Yue Chen, Douglas Manuel, Howard Morrison, Yang Mao.   

Abstract

Adverse health effects differ with various levels of obesity, but limited national data existed previously for the Canadian population. We examined the associations of sociodemographic and behavioral factors with obesity levels in Canada, and measured the impact of each level on major chronic diseases. Data were extracted from the 2003 Canadian Community Health Survey. We grouped overweight/obese participants aged 18 years and over into four levels based on body mass index (BMI, kg/m2): overweight (25.0 C29.9), class I obesity (30.0 C34.9), class II obesity (35 C39.9), and class III obesity (extreme/clinical obesity, BMI > or = 40.0). We used logistic regression models to identify potential risk factors for the obesity levels and to estimate adjusted odds ratios (ORs) for major chronic diseases related to each level. We calculated population attributable risks (PARs) to help understand the impact of obesity levels on these chronic diseases. The overall prevalence of obesity was 16.2% in men and 14.6% in women, and the prevalence of obesity III was 1.0% in men and 1.4% in women. All levels of obesity increased with age, but then decreased in elderly participants. The prevalence of diabetes, hypertension, heart disease, arthritis, and asthma increased with increasing BMI level, and the highest values appeared in participants at the obesity III level. PAR was highest in the obesity III group for hypertension, followed by diabetes, and lowest for heart disease. When correlated with risk factors, fewer statistically significant ORs, comparing to the normal weight category, appeared for obesity II and III levels than for overweight and obesity I. ORs for the combination of low education level, infrequent exercise, and low household income rose significantly with BMI levels until the obesity II level, and in obesity III level, the OR remained at the same level as for obesity II, most significantly in women. These results suggest that the impact of obesity on Canadians inverted exclamation mark health should be studied and dealt with by obesity level. The greatest impact of clinical obesity was on hypertension and diabetes control in Canada.

Entities:  

Mesh:

Year:  2007        PMID: 17721642      PMCID: PMC5901210          DOI: 10.1100/tsw.2007.216

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  8 in total

1.  How much energy is locked in the USA? Alternative metrics for characterising the magnitude of overweight and obesity derived from BRFSS 2010 data.

Authors:  Daniel D Reidpath; Mohd Masood; Pascale Allotey
Journal:  Int J Public Health       Date:  2013-09-18       Impact factor: 3.380

2.  Novel measurements of periaortic adipose tissue in comparison to anthropometric measures of obesity, and abdominal adipose tissue.

Authors:  C L Schlett; J M Massaro; S J Lehman; F Bamberg; C J O'Donnell; C S Fox; U Hoffmann
Journal:  Int J Obes (Lond)       Date:  2009-01-13       Impact factor: 5.095

3.  Cardiovascular Risk Factors and Atherogenic Indices in an Iranian Population: Birjand East of Iran.

Authors:  Toba Kazemi; Morteza Hajihosseini; Maryam Moossavi; Mina Hemmati; Masood Ziaee
Journal:  Clin Med Insights Cardiol       Date:  2018-02-20

4.  INSIG2 rs7566605 single nucleotide variant and global DNA methylation index levels are associated with weight loss in a personalized weight reduction program.

Authors:  Francesca Pirini; Sebastian Rodriguez-Torres; Bola Grace Ayandibu; María Orera-Clemente; Alberto Gonzalez-de la Vega; Fahcina Lawson; Roland J Thorpe; David Sidransky; Rafael Guerrero-Preston
Journal:  Mol Med Rep       Date:  2017-11-14       Impact factor: 2.952

5.  Adiposity Measures and Plasma Adipokines in Females with Rheumatoid and Osteoarthritis.

Authors:  Vanessa DeClercq; Yunsong Cui; Cynthia Forbes; Scott A Grandy; Melanie Keats; Louise Parker; Ellen Sweeney; Zhijie Michael Yu; Trevor J B Dummer
Journal:  Mediators Inflamm       Date:  2017-11-01       Impact factor: 4.711

6.  Chronic disease burden associated with overweight and obesity in Ireland: the effects of a small BMI reduction at population level.

Authors:  Karen Kearns; Anne Dee; Anthony P Fitzgerald; Edel Doherty; Ivan J Perry
Journal:  BMC Public Health       Date:  2014-02-10       Impact factor: 3.295

7.  Atherogenic Index of Plasma (AIP): A marker of cardiovascular disease.

Authors:  Shabnam Niroumand; Mohammad Khajedaluee; Majid Khadem-Rezaiyan; Maryam Abrishami; Mohammadreza Juya; Gholamhasan Khodaee; Maliheh Dadgarmoghaddam
Journal:  Med J Islam Repub Iran       Date:  2015-07-25

8.  Comparison of body mass index (BMI) with the CUN-BAE body adiposity estimator in the prediction of hypertension and type 2 diabetes.

Authors:  Vicente Martín; Verónica Dávila-Batista; Jesús Castilla; Pere Godoy; Miguel Delgado-Rodríguez; Nuria Soldevila; Antonio J Molina; Tania Fernandez-Villa; Jenaro Astray; Ady Castro; Fernando González-Candelas; José María Mayoral; José María Quintana; Angela Domínguez
Journal:  BMC Public Health       Date:  2016-01-27       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.